News & Analysis as of

Innovation UK Brexit

Hogan Lovells

UK Utilities regulation: a brave new world?

Hogan Lovells on

The UK Government has formally fired the starting gun on the refresh of its approach to economic regulation of the utilities sectors.  This: Since the UK left the EU, leveraging the flexibility in policy development that has...more

Dechert LLP

2020 Global Private Equity Outlook

Dechert LLP on

Dechert and Mergermarket assess market trajectories - Growing concerns over geopolitics and fear of a looming recession are the top challenges facing the private equity industry, according to the latest Private Equity...more

Hogan Lovells

Life Sciences and Health Care Horizons - 2018

Hogan Lovells on

Innovation in the life sciences and health care industries is occurring at a dizzying pace. Five years ago, anti-PD-1 antibodies from Merck and BMS had yet to be approved, CAR-T therapies were still in small-scale clinical...more

Jones Day

UK's Regulator Announces Its Top Priorities in the Lead Up to Brexit

Jones Day on

The Medicines and Healthcare products Regulatory Agency (MHRA), the UK's pharmaceutical and medical devices regulator, has recently released its 2017-2018 business plan. Of the 10 key priorities identified by the MHRA, life...more

Sheppard Mullin Richter & Hampton LLP

Top 12 EU Legal Developments to Watch in 2017

Sheppard Mullin’s EU team has created a list of major legal shifts that await General Counsel and Compliance Officers in the areas of competition, EU regulatory and trade in 2017. These challenges may have an impact on your...more

Hogan Lovells

Data Without Borders: Hogan Lovells Winnik Forum Addresses International Considerations for the Growth and Development of a...

Hogan Lovells on

The Internet of Things (“IoT”) connects markets and supply chains around the world. Industry, governments and consumers around the world are embracing IoT technologies to improve research and public policy, to accelerate...more

McDermott Will & Emery

Highlights from McDermott’s 2016 Pharmaceutical/Medtech Dealmaking Symposium

McDermott Will & Emery on

On October 25, 2016, McDermott Will & Emery held its fifth annual Pharmaceutical/Medtech Dealmaking Symposium in Cambridge, Massachusetts. The day consisted of a series of thought-provoking panels with leading dealmakers in...more

Foley & Lardner LLP

Brexit – Standards and Innovation: What’s Ahead?

Foley & Lardner LLP on

This article is the second in an ongoing series of blog posts by Foley & Lardner LLP on the implications of the June 23, 2016 referendum decision in the United Kingdom (“UK”) to exit the European Union (“EU”). The first blog...more

8 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide